CEO | Persuasive

We are seeking a hands-on CEO to lead the company through its next phase of final development and first commercialization. This role was created as the founding CEO transitions to a dedicated CTO position, taking full ownership of technology, IP, and regulatory matters. The incoming CEO focuses exclusively on commercial strategy, investor relations, and go-to-market execution.

The business case is strong with limited / no competition. The technology is entering the final development stage. Large-scale verification and validation will be done in the next 1-2 years while preparing for launching as a testing service in NL in parallel. 

The CEO’s role is to convert this foundation into a commercially sustainable business model, refine it for future scaling, and lead the company toward international expansion and long-term strategic relevance.

This is a CEO role requiring commercial strategy development and fundraising.

• Evaluate available business model options, select the most commercially viable path, and develop a 12 to 24-month execution plan covering go-to-market, pricing, and positioning for the European market with a view to US expansion.

• Secure €1 to 2M in the next funding round through active outreach to angels, corporate VCs, and strategic partners, building a credible financial narrative around the verification and validation timeline and commercialization milestones.

• Represent PERSUASIVE externally with clinicians, strategic partners, and investors, while preparing the company for first commercialization in Europe, including US expansion.

• Drive fundraising efforts by actively engaging with suitable investors and leveraging technical and commercial acumen

• Identify and remove barriers to adoption by spending time with customers to understand clinical applications, key stakeholders, hospital budgeting, workflows, training, and usage challenges, and translating these insights into action.

• Lead and refocus a small team on execution by setting clear priorities, ownership, and accountability, and eliminating non-essential activity.